PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsNew treatment targets inherited breast cancer

BioNews

New treatment targets inherited breast cancer

Published 9 June 2009 posted in News and appears in BioNews 304

Author

BioNews

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

A new drug treatment could help treat breast cancer in women affected by the hereditary form of the disease, two studies show. The findings, published in the journal Nature, show that drugs which target a protein called poly(ADP-ribose) polymerase-1 (PARP1) could be highly effective against tumours in patients...

A new drug treatment could help treat breast cancer in women affected by the hereditary form of the disease, two studies show. The findings, published in the journal Nature, show that drugs which target a protein called poly (ADP-ribose) polymerase 1 (PARP1) could be highly effective against tumours in patients with inherited breast cancer gene mutations. In one of the studies, carried out by researchers at the Institute of Cancer Research in London and Cambridge-based Company KuDOS, a PARP-blocking drug selectively killed off tumour cells that had mutations in either the BRCA1 or BRCA2 gene.


Most cases of breast cancer are not inherited, but around 5-10 per cent are due to a gene mutation. Women who have a mutation in either the BRCA1 or BRCA2 gene have a greatly increased lifetime risk of developing breast and ovarian cancer. The proteins made by these two genes are responsible for repairing DNA damage, a process that also involves PARP1. In people who inherit a faulty BRCA1 or BRCA2 gene, if a single cell acquires a mutation in the other, working copy of either gene then it can no longer repair DNA properly - a key step in the development of cancer. The scientists decided to see if by knocking out PARP1, they could inflict even more DNA damage in cancer cells with no working BRCA1/2 genes, and so trigger the self-destruction of these cells. Team leader Alan Ashworth likened this approach to 'removing two legs of a table'. He said that 'removing one leg is damaging but removing two causes the table to fall over'.


The researchers first tested their idea by blocking PARP1 gene activity in order to kill mouse embryo stem cells that lacked working BRCA1/2 genes. They found that cells with no BRCA1 activity were 57 times more sensitive to the drugs than normal cells, while those with no working BRCA2 were 133 times more sensitive. The team then tested their approach in human tumour cells with no working BRCA2 gene, injected into mice, and found that the PARP1 inhibitors killed the tumour cells but left the healthy surrounding cells unscathed.


The second study, carried out by researchers based at Sheffield University, showed similar results using PARP1-blockers to kill tumour cells lacking BRCA2 gene activity. Phase 1 clinical trials based on the new research are set to begin in a few months. The approach could also lead to new treatments for non-inherited forms of breast cancer, say the teams. Such therapies should have fewer side effects than many current anti-cancer drugs, since they do not affect healthy cells. Thomas Helleday, head of the Sheffield group, also suggested that drugs targeting PARP1 could be given as a preventative measure to people with BRCA1 or BRCA2 gene mutations, to stop tumours from developing. Currently, the only way in which such women can substantially reduce their risk is to have both their breasts and ovaries removed, before cancer develops.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 2 minutes read

Breast cancer gene linked to other cancers in men

by BioNews

Dutch researchers have confirmed that men who inherit a faulty version of the BRCA2 gene - linked to an increased risk of breast and ovarian cancer in women - are at a higher risk of certain other cancers. The scientists, based at Leiden University Medical Centre, found that men with BRCA2 gene...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 2 minutes read

Personalised cancer treatments show promise

by BioNews

Targeted cancer treatments, based on genetic profiling results, could soon become a reality. A team lead by researchers at the Dana-Farber Cancer Institute, in the US, has found that only lung tumours with a particular gene mutation are likely to respond to treatment with the drug gefitinib. The work is...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 2 minutes read

Personalised treatment for cancer?

by BioNews

A new DNA 'chip' could pave the way for breast cancer treatments tailored to individual patients, according to French biotechnology company Ipsogen. Alane Koki, the firm's scientific director, told delegates attending the fourth European Breast Cancer Conference in Hamburg that the breast cancer profile chip (BCPC) could be available this...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Washington state delays vote on stem cell research

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856